Roche acquires Irish biotechnology company Inflazome for €380m

This article was originally published here

The deal also allows Inflazome to secure additional contingent payments based on the achievement of certain predetermined milestones. Based in Dublin, Inflazome is engaged in the development of

The post Roche acquires Irish biotechnology company Inflazome for €380m appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply